|
⚲
|
| Keyboard |
| Reneo Pharmaceuticals Inc | |
|---|---|
| Ticker | OKUR |
| CIK # | 0001637715 |
| CUSIP | 68277Q105 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 12230 El Camino Real Suite 230, San Diego, CA 92130 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Onkure Therapeutics Inc | 2024-10-21 | 65.0 M | Exemption: 506(b) · Duration: One year or less · Commission: $3,250,000 · Revenue: Decline to Disclose |
| Reneo Pharmaceuticals Inc | 2020-12-21 | 47.4 M | Exemption: 506(b) · Remaining: $47,384,999 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001637715] | 10-K | |
| [0001637715] | 10-Q | |
| [0001637715] | 3 | |
| [0001637715] | 4 | |
| [0001637715] | 8-K | |
| [0001637715] | D | |
| [0001637715] | SC 13D | |
| [0001637715] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Saccomano Nicholas A
Class A Common Stock
|
2026-03-23 | Sell | 86 | $4.16 | 358 |
|
Leverone Jason A
Class A Common Stock
|
2026-03-23 | Sell | 301 | $4.16 | 1,252 |
|
Mathers Edward T
Class A Common Stock
|
2025-12-31 | Grant | 3,911 | $0.00 | |
|
Manke Isaac
Class A Common Stock
|
2025-12-31 | Grant | 5,258 | $0.00 | |
|
Leverone Jason A
Class A Common Stock
|
2025-12-22 | Sell | 302 | $2.97 | 897 |
|
Saccomano Nicholas A
Class A Common Stock
|
2025-12-22 | Sell | 87 | $2.97 | 258 |
|
Mathers Edward T
Class A Common Stock
|
2025-09-30 | Grant | 4,125 | $0.00 | |
|
Manke Isaac
Class A Common Stock
|
2025-09-30 | Grant | 5,545 | $0.00 | |
|
Class A Common Stock
|
2025-09-22 | Sell | 88 | $2.62 | 231 |
|
Class A Common Stock
|
2025-09-22 | Sell | 303 | $2.62 | 794 |
|
Mathers Edward T
Class A Common Stock
|
2025-06-30 | Grant | 4,694 | $0.00 | |
|
Manke Isaac
Class A Common Stock
|
2025-06-30 | Grant | 6,311 | $0.00 | |
|
Saccomano Nicholas A
Class A Common Stock
|
2025-06-23 | Sell | 88 | $2.38 | 209 |
|
Leverone Jason A
Class A Common Stock
|
2025-06-23 | Sell | 303 | $2.38 | 721 |
|
Manke Isaac
Stock Option (right to buy) · derivative
|
2025-05-28 | Grant | 7,650 | $0.00 | |
|
Phillips Andrew John
Stock Option (right to buy) · derivative
|
2025-05-28 | Grant | 7,650 | $0.00 | |
|
Carruthers R Michael
Stock Option (right to buy) · derivative
|
2025-05-28 | Grant | 7,650 | $0.00 | |
|
Grey Michael G
Stock Option (right to buy) · derivative
|
2025-05-28 | Grant | 7,650 | $0.00 | |
|
Jansen Valerie Malyvanh
Stock Option (right to buy) · derivative
|
2025-05-28 | Grant | 7,650 | $0.00 | |
|
Mathers Edward T
Stock Option (right to buy) · derivative
|
2025-05-28 | Grant | 7,650 | $0.00 | |
| showing 20 of 164 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 51 | 27,483,951 |
| 2025-12-31 | 43 | 11,075,514 |
| 2025-09-30 | 42 | 10,220,031 |
| 2025-06-30 | 49 | 10,776,835 |
| 2025-03-31 | 48 | 11,945,415 |
| 2024-12-31 | 53 | 11,853,696 |
| 2024-09-30 | 1 | 3,200 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Y-Intercept Hong Kong Ltd | [2026-06-30] | SOLE | 11,288 | 11,288 |
| Trust Co of Toledo NA /OH/ | [2026-06-30] | SOLE | 136 | 136 | Prev | Page 1 | Next |